News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Opinion|Videos|March 31, 2025

Advanced Metastatic Gastric Adenocarcinoma: Treatment Approaches

Panelists discuss how multidisciplinary strategies incorporating chemotherapy, targeted agents, and immunotherapy are strategically sequenced to optimize outcomes for patients with advanced metastatic gastric adenocarcinoma.

Episodes in this series

3 experts are featured in this series.

EP. 1 Esophageal/Gastric Adenocarcinoma Standard of Care

3 experts are featured in this series.

EP. 2 Adjuvant Nivolumab in Gastric Cancers and CheckMate 8HW

3 experts are featured in this series.

EP. 3 Gastric Adenocarcinoma: Current Treatment Landscape

3 experts are featured in this series.

EP. 4 Advanced Metastatic Gastric Adenocarcinoma: Treatment Approaches

3 experts are featured in this series.

EP. 5 Second-Line Treatment for Gastric Adenocarcinoma

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Related Content

4 experts are featured in this series.

High-Risk Patient Populations and Therapy Selection for EGFR-Mutant mNSCLC

ByMartin Dietrich, MD, PhD,Danny Nguyen, MD,Joshua K. Sabari, MD,Alexander Spira, MD, PhD, FACP, FASCO

December 24th 2025

4 experts are featured in this series.

CNS Disease and Intracranial Management in EGFR-Mutant mNSCLC

ByMartin Dietrich, MD, PhD,Danny Nguyen, MD,Joshua K. Sabari, MD,Alexander Spira, MD, PhD, FACP, FASCO

December 24th 2025

DFLOT Implementation: Surgical Timing, Patient Selection, and the Evolving Role of Adjuvant Immunotherapy

ByRutika Mehta, MD, MPH,Sharon Shiraga, MD, FACS,Sreenivasa R. Chandana, MD, PhD,Jacques-Pierre Fontaine, MD

December 22nd 2025

MATTERHORN Trial Design and DFLOT Adoption: Integrating Immunotherapy Into Perioperative Practice

ByRutika Mehta, MD, MPH,Sharon Shiraga, MD, FACS,Sreenivasa R. Chandana, MD, PhD,Jacques-Pierre Fontaine, MD

December 22nd 2025

1 expert is featured in this series.

Introducing COPERNICUS: Clinical Gaps and the Rationale for a New First-Line Strategy

ByEdgardo Santos, MD, FACP, FASCO

December 22nd 2025

Trending on CancerNetwork

Spotlighting the Top 10 FDA Oncology Approvals in 2025

A Look Back on the Top 10 Oncology Interviews in 2025

Zovegalisib Combo Confers Efficacy Benefit in PIK3CA-Mutated Breast Cancer

‘Relatively Low’ AEs Noted With Durvalumab/FLOT in Gastric/GEJ Cancer

Top 10 Peer-Reviewed ONCOLOGY Articles Shaping Cancer Care in 2025